Session Type
Meeting
Search Results for pulmonary
Abstract Number: 115
SHM Converge 2021
Background: Approximately 10% adults with Sickle Cell disease (SCD) has Pulmonary hypertension (PHTN). There are several etiologies like hypoxia driven and microvascular obstruction contributing to PHTN. However, the in-hospital outcomes of PHTN on SCD has not been well studied. Methods: We queried 2018 National Inpatient Sample (NIS) database to identify SCD and different types of […]
Abstract Number: 115
Hospital Medicine 2020, Virtual Competition
Background: The Choosing Wisely campaign discourages CT imaging in low-risk patients with suspected pulmonary embolism (PE) (e.g., low clinical probability and negative d-dimer). Few studies have investigated patient, provider, or operational characteristics associated with overuse of CT imaging. One possible approach to this research question is to examine variability in diagnostic yield (i.e., the percentage […]
Abstract Number: 138
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Chronic Obstructive Pulmonary Disease (COPD) is a lung disease characterized by chronic, irreversible airway obstruction that can precipitate into acute exacerbations (AECOPD) of cough, dyspnea and sputum production, often requiring hospitalization. Hospital systems aiming to improve outcomes for patients with AECOPD are testing innovative approaches to care in the acute care setting. To enroll […]
Abstract Number: 139
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: The In-hospital Mortality for Pulmonary embolism using Claims daTa (IMPACT) rule has been validated in a number of commercial and all-payer claims databases; classifying pulmonary embolism (PE) patients into low- and higher-risk in-hospital all-cause mortality categories with a sensitivity of 87% and specificity of 47%. We sought to directly compare the accuracy of IMPACT […]
Abstract Number: 140
SHM Converge 2023
Background: Even after successful treatment, many patients with tuberculosis (TB) suffer from post-TB sequelae. These may be structural complications (such as bronchiectasis, broncholithiasis, residual cavitation, COPD), infectious complications (such as COPD exacerbations, Aspergillus fumigatus infections, non-tubercular mycobacterial infections, pneumonia), or psychosocial morbidities (such as anxiety, depression, financial burden).[1] The impact of post-TB sequelae is not […]
Abstract Number: 144
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Venous thromboembolism (VTE) in hospitalized medically ill patients is a leading preventable cause of morbidity and mortality in the United States. About half of VTE events occur following discontinuation of standard-duration in-hospital prophylaxis and hospital discharge. The APEX study evaluated Betrixaban for in-hospital to home VTE prophylaxis and is the first FDA approved anticoagulant […]
Abstract Number: 145
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Venous thromboembolism (VTE) in hospitalized medically ill patients is a leading preventable cause of morbidity and mortality in the United States. About half of VTE events occur following discontinuation of standard-duration in-hospital prophylaxis and hospital discharge. The APEX study evaluated Betrixaban for in-hospital to home VTE prophylaxis and is the first FDA approved anticoagulant […]
Abstract Number: 152
Hospital Medicine 2020, Virtual Competition
Background: Pulmonary arterial hypertension (PAH) is a progressively debilitating disorder characterized by sustained increases in pulmonary vascular resistance and pulmonary arterial pressure, which eventually leads to right-sided heart failure. Current therapies for PAH work predominately as vasodilators to target symptoms, rather than focusing on the initial signals that promote disease progression. These therapies have proved […]
Abstract Number: 156
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Prognostic risk scores allow clinicians to rapidly identify patients with acute pulmonary embolism (PE) at a low risk for mortality and morbidity. Current guidelines recommend that these patients be considered for outpatient treatment. Despite this, most patients with low-risk PE are still hospitalized for monitoring and initiation of anticoagulation. Interventions to improve provider awareness […]
Abstract Number: 168
SHM Converge 2021
Background: D-dimer is one of the most commonly used tests because of its high sensitivity, but a high false positive rate prevents healthcare providers from efficiently diagnosing pulmonary embolism (PE). This leads to many patients unnecessarily undergoing CT pulmonary angiography (CTPA) scans in the emergency department (ED). This study sought to determine if there is […]